HLA alleles, disease severity, and age associate with T-cell responses following infection with SARS-CoV-2

[1]  Chloe H. Lee,et al.  HLA‐dependent variation in SARS‐CoV‐2 CD8 + T cell cross‐reactivity with human coronaviruses , 2022, Immunology.

[2]  Michael D Healy,et al.  Allelic variation in class I HLA determines CD8+ T cell repertoire shape and cross-reactive memory responses to SARS-CoV-2 , 2021, Science Immunology.

[3]  A. Karlsson,et al.  Identification of resident memory CD8+ T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissue , 2021, Science Immunology.

[4]  J. Mascola,et al.  Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants , 2021, Science.

[5]  Calliope A. Dendrou,et al.  An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease , 2021, Nature immunology.

[6]  Chloe H. Lee,et al.  HLA-dependent variation in SARS-CoV-2 CD8+ T cell cross-reactivity with human coronaviruses , 2021, bioRxiv.

[7]  R. Scheuermann,et al.  Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals , 2021, Cell Reports Medicine.

[8]  F. Balloux,et al.  Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 infection , 2021, medRxiv.

[9]  E. Shin,et al.  SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells , 2021, Nature Communications.

[10]  A. García-Sastre,et al.  Immunological imprinting of the antibody response in COVID-19 patients , 2021, Nature Communications.

[11]  M. Davenport,et al.  Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection , 2021, Nature Medicine.

[12]  S. Kent,et al.  CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity , 2021, Immunity.

[13]  A. Tonevitsky,et al.  Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19 , 2021, Frontiers in Immunology.

[14]  P. Kellam,et al.  T cell response to SARS-CoV-2 infection in humans: A systematic review , 2021, PLoS ONE.

[15]  A. Sette,et al.  Adaptive immunity to SARS-CoV-2 and COVID-19 , 2021, Cell.

[16]  A. Casadevall,et al.  SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals. , 2021, The Journal of clinical investigation.

[17]  Bjoern Peters,et al.  Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection , 2021, Science.

[18]  P. Klenerman,et al.  T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses , 2020, Nature Communications.

[19]  R. Palsson,et al.  Clinical spectrum of coronavirus disease 2019 in Iceland: population based cohort study , 2020, BMJ.

[20]  P. Rosenstiel,et al.  Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19 , 2020, Immunity.

[21]  R. Kennedy,et al.  SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates , 2020, The Lancet.

[22]  Zhènglì Shí,et al.  Characteristics of SARS-CoV-2 and COVID-19 , 2020, Nature Reviews Microbiology.

[23]  M. Lipsitch,et al.  Cross-reactive memory T cells and herd immunity to SARS-CoV-2 , 2020, Nature Reviews Immunology.

[24]  A. Sette,et al.  Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19 , 2020, Cell.

[25]  H. Rammensee,et al.  SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition , 2020, Nature immunology.

[26]  P. Sopp,et al.  Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 , 2020, Nature Immunology.

[27]  A. Gylfason,et al.  Humoral Immune Response to SARS-CoV-2 in Iceland , 2020, The New England journal of medicine.

[28]  J. Deelen,et al.  Correlation of the two most frequent HLA haplotypes in the Italian population to the differential regional incidence of Covid-19 , 2020, Journal of translational medicine.

[29]  S. Mallal,et al.  Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans , 2020, Science.

[30]  Martin Linster,et al.  SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls , 2020, Nature.

[31]  Morten Nielsen,et al.  Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19 , 2020, Cell.

[32]  S. Tavakolpour,et al.  Lymphopenia during the COVID-19 infection: What it shows and what can be learned , 2020, Immunology Letters.

[33]  M. V. von Herrath,et al.  Faculty Opinions recommendation of Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. , 2020, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[34]  J. Greenbaum,et al.  Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals , 2020, Cell.

[35]  Abhinav Nellore,et al.  Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2 , 2020, Journal of Virology.

[36]  Kari Stefansson,et al.  Spread of SARS-CoV-2 in the Icelandic Population , 2020, The New England journal of medicine.

[37]  Reprint of: Mahalanobis, P.C. (1936) "On the Generalised Distance in Statistics." , 2018, Sankhya A.

[38]  M. Nielsen,et al.  NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data , 2017, The Journal of Immunology.

[39]  Kari Stefansson,et al.  Graphtyper enables population-scale genotyping using pangenome graphs , 2017, Nature Genetics.

[40]  Morten Nielsen,et al.  NetMHCpan 4.0: Improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data , 2017, bioRxiv.

[41]  Luca Scrucca,et al.  mclust 5: Clustering, Classification and Density Estimation Using Gaussian Finite Mixture Models , 2016, R J..

[42]  M. Ravid,et al.  A Six-Year Follow-up Study , 2016 .

[43]  Bjarni V. Halldórsson,et al.  Large-scale whole-genome sequencing of the Icelandic population , 2015, Nature Genetics.

[44]  Cheng-Li Lin,et al.  A population-based cohort study. , 2015 .

[45]  M. de Carvalho,et al.  Jackknife Euclidean Likelihood-Based Inference for Spearman's Rho , 2012 .

[46]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[47]  G. Kaplan,et al.  Functional Capacity of Mycobacterium tuberculosis-Specific T Cell Responses in Humans Is Associated with Mycobacterial Load , 2011, The Journal of Immunology.

[48]  Hong Yang,et al.  Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study , 2011, The Journal of Immunology.

[49]  G. Pantaleo,et al.  Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease , 2011, Nature Medicine.

[50]  Pall I. Olason,et al.  Detection of sharing by descent, long-range phasing and haplotype imputation , 2008, Nature Genetics.

[51]  M. Roederer,et al.  T-cell quality in memory and protection: implications for vaccine design , 2008, Nature Reviews Immunology.

[52]  Lin‐Fa Wang,et al.  Duration of Antibody Responses after Severe Acute Respiratory Syndrome , 2007, Emerging infectious diseases.

[53]  Rachel E. Owen,et al.  Loss of T cell responses following long-term cryopreservation. , 2007, Journal of immunological methods.

[54]  H. Robinson,et al.  Multiple-Cytokine-Producing Antiviral CD4 T Cells Are Functionally Superior to Single-Cytokine-Producing Cells , 2007, Journal of Virology.

[55]  James Robinson,et al.  IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex , 2003, Nucleic Acids Res..

[56]  Kári Stefánsson,et al.  Protection of privacy by third-party encryption in genetic research in Iceland , 2000, European Journal of Human Genetics.